Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 11, 2014
April 22, 2020
324bb7a2-737c-4021-a1b4-e156ceed5ab8
Related Documents
Malaria: Developing Drugs for Treatment: Draft Guidance for Industry
Guidance DocumentSeptember 23, 2025Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers
Guidance DocumentDecember 9, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox